BMJ Publishing Group, Practical Neurology, 5(22), p. 344-357, 2022
DOI: 10.1136/practneurol-2022-003370
Full text: Unavailable
Infection in people with multiple sclerosis (MS) is of major concern, particularly for those receiving disease-modifying therapies. This article explores the risk of infection in people with MS and provides guidance—developed by Delphi consensus by specialists involved in their management—on how to screen for, prevent and manage infection in this population.